The Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL: Updated Results from the DUO Crossover Extension Study

Matthew S Davids, Bryone J Kuss, Peter Hillmen, Marco Montillo, James Essell, Nicole Lamanna, Zsolt Nagy, Constantine S Tam, Stephan Stilgenbauer, Paolo Ghia, Julio Delgado, Le NgocDiep, Stephanie Lustgarten, David T Weaver, Ulrich Jaeger